Results 181 to 190 of about 31,626 (234)

SEROPOSITIVITY TO HIV-1 AND HIV-2

Lancet, The, 1987
Francis Barin, Richard Hayes, Peter G Smith   +2 more
exaly   +3 more sources

SEROPOSITIVITY TO HIV IN HODGKIN'S DISEASE

Lancet, The, 1988
J F, Devars du Mayne, F, Teillet-Thiebaud, M, Pulick, F, Courtois   +3 more
exaly   +3 more sources

HIV Seropositivity and Deliberate Weight Gain

New England Journal of Medicine, 1990
J, Smith, C L, Birmingham
exaly   +3 more sources

HIV seropositivity in paid blood donors

Lancet, The, 1992
exaly   +3 more sources

MANAGEMENT OF RETINOBLASTOMA WITH HIV SEROPOSITIVITY

RETINAL Cases & Brief Reports, 2020
Purpose: To report a case of retinoblastoma with concomitant association with HIV seropositivity and its management. Methods: A retrospective case report of a 3-year-old male child presenting with right eye Group B and left eye Group E retinoblastoma with simultaneous positivity for
Abhinav, Dhami, Anita, Ramesh, Vikas, Khetan   +2 more
openaire   +2 more sources

Disclosure of HIV seropositivity

Journal of Clinical Psychology, 1999
Deciding whether or not to disclose one's HIV-positive status to another person is an important decision: the way each person experiences and copes with the illness is reflected in this choice. We conducted a study of 174 patients (29.3% of women) to examine how the decision to disclose or conceal was made, as well as its subjective and social ...
A, Lévy, F, Laska, A, Abelhauser, J F, Delfraissy, C, Goujard, F, Boué, J, Dormont   +6 more
openaire   +2 more sources

HIV-seropositive thrombocytopenia

AIDS, 1991
The action of zidovudine when administered to individuals with severe HIV thrombocytopenia was investigated. Four individuals with platelets less than 50 x 10(9)/l and CD4 cells greater than 200 x 10(6)/l were treated with 600 mg zidovudine per day for 6 weeks, no drug for 6 weeks, 1200 mg zidovudine per day for 6 weeks, then no drug for 6 weeks ...
A, Boyar, G, Beall
openaire   +2 more sources

Seropositivity for HIV at Alternate Sites

JAMA: The Journal of the American Medical Association, 1988
To the Editor.— Shortly after the Food and Drug Administration licensed thetubeenzyme-linked immunosorbent assay for human immunodeficiency virus (HIV) testing, the Centers for Disease Control made funds available for the development and implementation of "alternate testing sites." The goal of the program was to protect the nation's blood supply by ...
J C, Grabau, D L, Morse
openaire   +2 more sources

Disclosing HIV seropositivity to significant others

AIDS, 1993
To examine gay men's patterns of self-disclosure of HIV seropositivity to friends, lovers, relatives and colleagues; to assess the effects of disclosure; and to identify reasons for not disclosing to particular individuals.Longitudinal questionnaire survey of gay men.A total of 163 HIV-positive men participating in the AIDS Behavioral Research Project,
R B, Hays, L, McKusick, L, Pollack, R, Hilliard, C, Hoff, T J, Coates   +5 more
openaire   +2 more sources

Dental Caries in HIV-seropositive Women

Journal of Dental Research, 2004
Reports that compare dental caries indices in HIV-seropositive (HIV+) subjects with HIV-seronegative (HIV-) subjects are rare. The objective of this study was to determine if there was an association between HIV infection and dental caries among women enrolled in the Women’s Interagency HIV Study.
J A, Phelan, R, Mulligan, E, Nelson, J, Brunelle, M E A F, Alves, M, Navazesh, D, Greenspan   +6 more
openaire   +2 more sources